While early immunohistochemical analyses of neural tumors using pan-Trk antibodies confirmed presence of at least one neurotrophin receptor34, little insight could be gained as to which TRK (or TRKs) were present or if receptor distribution differed between neural and non-neural tissue. The gene discussed is NTRK1; the disease is nervous system cancer.